In the present study, examination of more than 50 HBE cell lines, grouped by disease background, allowed to extend our previous findings and demonstrate that TGF-β1 inhibits CFTR in HBE cells from CF, COPD, and IPF lungs, compared to controls without chronic disease (Figure 4C). This evidence concerns the gene TGFB1 and cystic fibrosis.